TrialPloS one2018

The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial.

Ken Iseri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.